ProShare Advisors’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $127K | Sell |
|
|||||
|
2025
Q1 | $179K | Sell |
|
|||||
|
2024
Q4 | $246K | Buy |
|
|||||
|
2024
Q3 | $201K | Buy |
|
|||||
|
2024
Q2 | $190K | Sell |
|
|||||
|
2024
Q1 | $267K | Buy |
|
|||||
|
2023
Q4 | $245K | Buy |
|
|||||
|
2023
Q3 | $202K | Buy |
|
|||||
|
2023
Q2 | $529K | Buy |
|
|||||
|
2023
Q1 | $462K | Sell |
|
|||||
|
2022
Q4 | $600K | Buy |
|
|||||
|
2022
Q3 | $431K | Buy |
|
|||||
|
2022
Q2 | $556K | Sell |
|
|||||
|
2022
Q1 | $685K | Sell |
|
|||||
|
2021
Q4 | $1.4M | Sell |
|
|||||
|
2021
Q3 | $1.63M | Sell |
|
|||||
|
2021
Q2 | $1.96M | Buy |
|
|||||
|
2021
Q1 | $1.7M | Buy |
|
|||||
|
2020
Q4 | $876K | Buy |
|
|||||
|
2020
Q3 | $264K | Buy |
|
|||||
|
2020
Q2 | $263K | Buy |
|